Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The urinary 1 H-NMR metabolomics profile of an italian autistic children population and their unaffected siblings.

Lussu M, Noto A, Masili A, Rinaldi AC, Dessì A, De Angelis M, De Giacomo A, Fanos V, Atzori L, Francavilla R.

Autism Res. 2017 Jun;10(6):1058-1066. doi: 10.1002/aur.1748. Epub 2017 Mar 11.

PMID:
28296209
2.

Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.

Gevi F, Zolla L, Gabriele S, Persico AM.

Mol Autism. 2016 Nov 24;7:47. eCollection 2016.

3.

Metabolomics Study of Urine in Autism Spectrum Disorders Using a Multiplatform Analytical Methodology.

Diémé B, Mavel S, Blasco H, Tripi G, Bonnet-Brilhault F, Malvy J, Bocca C, Andres CR, Nadal-Desbarats L, Emond P.

J Proteome Res. 2015 Dec 4;14(12):5273-82. doi: 10.1021/acs.jproteome.5b00699. Epub 2015 Nov 23.

PMID:
26538324
4.

Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls.

Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK.

J Proteome Res. 2010 Jun 4;9(6):2996-3004. doi: 10.1021/pr901188e.

5.

The urinary metabolomics profile of an Italian autistic children population and their unaffected siblings.

Noto A, Fanos V, Barberini L, Grapov D, Fattuoni C, Zaffanello M, Casanova A, Fenu G, De Giacomo A, De Angelis M, Moretti C, Papoff P, Ditonno R, Francavilla R.

J Matern Fetal Neonatal Med. 2014 Oct;27 Suppl 2:46-52. doi: 10.3109/14767058.2014.954784.

PMID:
25284177
6.

Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder.

Khaled EM, Meguid NA, Bjørklund G, Gouda A, Bahary MH, Hashish A, Sallam NM, Chirumbolo S, El-Bana MA.

Metab Brain Dis. 2016 Dec;31(6):1419-1426. Epub 2016 Jul 13.

PMID:
27406246
7.

Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.

Wolahan SM, Hirt D, Glenn TC.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25.

8.

Identification of metabolic pathway disturbances using multimodal metabolomics in autistic disorders in a Middle Eastern population.

Bitar T, Mavel S, Emond P, Nadal-Desbarats L, Lefèvre A, Mattar H, Soufia M, Blasco H, Vourc'h P, Hleihel W, Andres CR.

J Pharm Biomed Anal. 2018 Apr 15;152:57-65. doi: 10.1016/j.jpba.2018.01.007. Epub 2018 Feb 3.

PMID:
29414019
9.

1H-13C NMR-based urine metabolic profiling in autism spectrum disorders.

Mavel S, Nadal-Desbarats L, Blasco H, Bonnet-Brilhault F, Barthélémy C, Montigny F, Sarda P, Laumonnier F, Vourc'h P, Andres CR, Emond P.

Talanta. 2013 Sep 30;114:95-102. doi: 10.1016/j.talanta.2013.03.064. Epub 2013 Apr 9.

10.

Empathic responding in preschool-aged children with familial risk for autism.

McDonald NM, Murphy HG, Messinger DS.

Autism Res. 2017 Oct;10(10):1621-1628. doi: 10.1002/aur.1819. Epub 2017 Jun 12.

11.

Measurement of urine indolylacroylglycine is not useful in the diagnosis or dietary management of autism.

Dalton NR, Chandler S, Turner C, Charman T, Pickles A, Simonoff E, Baird G.

Autism Res. 2017 Mar;10(3):408-413. doi: 10.1002/aur.1688. Epub 2016 Aug 29.

PMID:
27569540
12.

Language and motor skills in siblings of children with autism spectrum disorder: A meta-analytic review.

Garrido D, Petrova D, Watson LR, Garcia-Retamero R, Carballo G.

Autism Res. 2017 Nov;10(11):1737-1750. doi: 10.1002/aur.1829. Epub 2017 Jul 7. Review.

PMID:
28685955
13.

Mid-childhood outcomes of infant siblings at familial high-risk of autism spectrum disorder.

Shephard E, Milosavljevic B, Pasco G, Jones EJ, Gliga T, Happé F, Johnson MH, Charman T; BASIS Team.

Autism Res. 2017 Mar;10(3):546-557. doi: 10.1002/aur.1733. Epub 2016 Nov 29. Erratum in: Autism Res. 2017 Dec;10 (12 ):2056-2057.

14.

Combined 1H-NMR and 1H-13C HSQC-NMR to improve urinary screening in autism spectrum disorders.

Nadal-Desbarats L, Aïdoud N, Emond P, Blasco H, Filipiak I, Sarda P, Bonnet-Brilhault F, Mavel S, Andres CR.

Analyst. 2014 Jul 7;139(13):3460-8. doi: 10.1039/c4an00552j.

PMID:
24841505
15.

RNA sequencing of transformed lymphoblastoid cells from siblings discordant for autism spectrum disorders reveals transcriptomic and functional alterations: Evidence for sex-specific effects.

Tylee DS, Espinoza AJ, Hess JL, Tahir MA, McCoy SY, Rim JK, Dhimal T, Cohen OS, Glatt SJ.

Autism Res. 2017 Mar;10(3):439-455. doi: 10.1002/aur.1679. Epub 2016 Aug 16.

PMID:
27529825
16.

Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites.

Mussap M, Noto A, Fanos V.

Expert Rev Mol Diagn. 2016 Aug;16(8):869-81. doi: 10.1080/14737159.2016.1202765. Epub 2016 Jun 30. Review.

PMID:
27310602
17.

Non-ASD outcomes at 36 months in siblings at familial risk for autism spectrum disorder (ASD): A baby siblings research consortium (BSRC) study.

Charman T, Young GS, Brian J, Carter A, Carver LJ, Chawarska K, Curtin S, Dobkins K, Elsabbagh M, Georgiades S, Hertz-Picciotto I, Hutman T, Iverson JM, Jones EJ, Landa R, Macari S, Messinger DS, Nelson CA, Ozonoff S, Saulnier C, Stone WL, Tager-Flusberg H, Webb SJ, Yirmiya N, Zwaigenbaum L.

Autism Res. 2017 Jan;10(1):169-178. doi: 10.1002/aur.1669. Epub 2016 Jul 15.

18.

Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach.

Caboni P, Meloni A, Lussu M, Carta E, Barberini L, Noto A, Deiana SF, Mereu R, Ragusa A, Paoletti AM, Melis GB, Fanos V, Atzori L.

J Matern Fetal Neonatal Med. 2014 Oct;27 Suppl 2:4-12. doi: 10.3109/14767058.2014.956403.

PMID:
25284171
19.

Risk of Psychiatric and Neurodevelopmental Disorders Among Siblings of Probands With Autism Spectrum Disorders.

Jokiranta-Olkoniemi E, Cheslack-Postava K, Sucksdorff D, Suominen A, Gyllenberg D, Chudal R, Leivonen S, Gissler M, Brown AS, Sourander A.

JAMA Psychiatry. 2016 Jun 1;73(6):622-9. doi: 10.1001/jamapsychiatry.2016.0495.

PMID:
27145529
20.

Is Taurine a Biomarker in Autistic Spectrum Disorder?

Park E, Cohen I, Gonzalez M, Castellano MR, Flory M, Jenkins EC, Brown WT, Schuller-Levis G.

Adv Exp Med Biol. 2017;975 Pt 1:3-16. doi: 10.1007/978-94-024-1079-2_1.

PMID:
28849439

Supplemental Content

Support Center